Form 4: Repligen CFO Sells Shares Under 10b5-1 Plan

Repligen Corporation's CFO, Jason K. Garland, has sold shares of common stock as part of a pre-arranged trading plan.

Summary

• Jason K. Garland, Chief Financial Officer of Repligen Corporation (RGEN), reported a transaction on June 25, 2026.
• Garland sold 733 shares of common stock at a price of $145 per share.
• This transaction was executed under a Rule 10b5-1 trading plan adopted on December 8, 2025.
• Following the sale, Garland beneficially owns 19,359 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard insider stock sale executed under a pre-arranged plan, which is a common practice and does not inherently signal negative sentiment about the company's prospects.

Negatives

• The CFO of Repligen Corporation sold a portion of their holdings.

Future Outlook

The filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The use of a Rule 10b5-1 plan indicates a pre-planned sale, often used by executives to diversify holdings or manage personal finances without appearing to trade on material non-public information.

Stakeholder Impact

• Shareholders: The sale by the CFO may be perceived by some shareholders as a lack of confidence, although the use of a 10b5-1 plan mitigates this concern as it was pre-planned.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Key Dates

Keywords

Repligen Corporation, RGEN, Form 4, Insider Trading, Stock Sale, Rule 10b5-1, Jason K. Garland, CFO